Risk Assessment and Prevention of Venous Thromboembolism: Challenges and Practical Strategies for the Federal Healthcare Professional
Co-sponsored by the Duke University School of Medicine and Med-IQ.
Time to complete: 60 Minutes
- 1.0 AMA PRA Category 1 Credit(s)™
- 1.0 Accreditation Council for Pharmacy Education (ACPE)
Overview: In January 2010, the Duke University School of Medicine and Med-IQ convened a roundtable of medical experts in venous thromboembolism (VTE) to discuss the recognition and prevention of this condition within the federal healthcare system. These experts reviewed and compared the challenges of deep vein thrombosis and pulmonary embolism risk assessment and thromboprophylaxis in the Department of Veteran Affairs (VA) and active-duty military branches with challenges encountered in general clinical practice. This discussion is particularly timely, given the recent focus on VTE as a prominent public health problem by a number of government bodies and national organizations, including the VA, the United States Surgeon General, and the National Quality Forum. This article focuses on the prevention of VTE in the federal healthcare system and includes key excerpts from the roundtable discussion.
Thomas L. Ortel, MD, PhD
Philip C. Comp, MD, PhD
Stuart T. Haines, PharmD, FCCP, BCPS
Col. (Ret.) John B. Holcomb, MD, FACS
This activity has been approved for AMA PRA Category 1 Credit™.
This activity is supported by an educational grant from Ortho-McNeil™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.